Education Session
605 - Validating Per Annex 1
11 November 12.45-15.45
ISPE CEUs: 0.25
Tracks: RegulatoryQuality
Sponsored by the ISPE SPP Community of Practice (COP)
Annex 1 to the EU GMP Guidelines, covering sterile medicinal products, was revised and updated in 2008. The revisions updated four main areas:
- Classification of environmental cleanliness of clean rooms, and associated text
- Guidance on media simulations
- Guidance on bio-burden monitoring
- Guidance on capping of freeze-dried vials
This session will address the real world implementation of these requirements. What changes from past practices are required for on-going and periodic revalidation of facilities? Case studies from pharma company implementations of the revised guidance for requirements during capping will be discussed.
How you will Benefit
At the end of this session, participants will be able to:
- Apply knowledge of the changing regulatory environment to validation of sterile pharmaceutical operations in the EU
Who Should Attend
Professionals who are responsible for designing, reviewing, testing, operating, qualifying or validating equipment and systems for sterile pharmaceutical manufacturing
ISPE Communities of Practice (COPs)
C&Q, Containment, HVAC, and SPP
View the ISPE Community of Practice (COP) Guide
Session Leader
- Vincent Cebular, Vice President Compliance Ops, IPS USA
Session Presenters
- Janet Bowen, Dir Compliance/Quality Sys, Commissioning Agents, Inc USA
- Sterling Kline, R.A., Director, Project Development, IPS USA
